Engineering chimeric antigen receptor-T cells for cancer treatment
Abstract Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment.Recently, chimeric antigen vush gloss bullet vibrator receptor (CAR) T-cell therapy has been successfully applied in the treatment of B-cell malignancies, underscoring its great pot